全文获取类型
收费全文 | 2450672篇 |
免费 | 179588篇 |
国内免费 | 4520篇 |
专业分类
耳鼻咽喉 | 36393篇 |
儿科学 | 80173篇 |
妇产科学 | 69449篇 |
基础医学 | 345679篇 |
口腔科学 | 71000篇 |
临床医学 | 211866篇 |
内科学 | 481786篇 |
皮肤病学 | 54763篇 |
神经病学 | 195337篇 |
特种医学 | 98027篇 |
外国民族医学 | 1056篇 |
外科学 | 377422篇 |
综合类 | 53990篇 |
现状与发展 | 7篇 |
一般理论 | 789篇 |
预防医学 | 177640篇 |
眼科学 | 56729篇 |
药学 | 183662篇 |
5篇 | |
中国医学 | 5158篇 |
肿瘤学 | 133849篇 |
出版年
2018年 | 24438篇 |
2016年 | 21101篇 |
2015年 | 23447篇 |
2014年 | 32667篇 |
2013年 | 50100篇 |
2012年 | 67204篇 |
2011年 | 71272篇 |
2010年 | 42406篇 |
2009年 | 40412篇 |
2008年 | 68041篇 |
2007年 | 73621篇 |
2006年 | 73879篇 |
2005年 | 71993篇 |
2004年 | 70094篇 |
2003年 | 67985篇 |
2002年 | 66764篇 |
2001年 | 115697篇 |
2000年 | 119649篇 |
1999年 | 101340篇 |
1998年 | 27676篇 |
1997年 | 25004篇 |
1996年 | 24732篇 |
1995年 | 23396篇 |
1994年 | 22018篇 |
1993年 | 20488篇 |
1992年 | 79066篇 |
1991年 | 76926篇 |
1990年 | 75099篇 |
1989年 | 72681篇 |
1988年 | 67316篇 |
1987年 | 66351篇 |
1986年 | 62722篇 |
1985年 | 59806篇 |
1984年 | 44969篇 |
1983年 | 38034篇 |
1982年 | 22459篇 |
1981年 | 20468篇 |
1979年 | 41792篇 |
1978年 | 29403篇 |
1977年 | 25320篇 |
1976年 | 23274篇 |
1975年 | 25968篇 |
1974年 | 30545篇 |
1973年 | 29525篇 |
1972年 | 27864篇 |
1971年 | 25724篇 |
1970年 | 24372篇 |
1969年 | 22947篇 |
1968年 | 21282篇 |
1967年 | 19126篇 |
排序方式: 共有10000条查询结果,搜索用时 375 毫秒
991.
992.
Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis. 总被引:4,自引:1,他引:3
下载免费PDF全文
![点击此处可从《Annals of the rheumatic diseases》网站下载免费的PDF全文](/ch/ext_images/free.gif)
M Gattorno P Picco A Buoncompagni F Stalla P Facchetti M P Sormani V Pistoia 《Annals of the rheumatic diseases》1996,55(4):243-247
OBJECTIVE: To determine the expression of tumour necrosis factor alpha (TNF alpha) and its soluble receptors (p55 and p75) in the sera and synovial fluid of patients with juvenile chronic arthritis (JCA), and their correlation with disease activity parameters. METHODS: Ninety eight sera from 45 patients with JCA (14 systemic, 12 polyarticular, 19 pauciarticular), 20 sera from age matched healthy controls, and five synovial fluids from five antinuclear antibody (ANA) positive pauciarticular JCA patients were tested for the presence of TNF alpha, soluble TNF receptors p55 and p75 (sTNFRp55, sTNFRp75), and interleukin-6 (IL-6) by an enzyme amplified sensitivity immunoassay. Physician global estimate of disease activity, weekly fever score and joint score, C reactive protein (CRP), erythrocyte sedimentation rate (ESR), and haemoglobin concentration were evaluated as parameters of disease activity. The expression of p55 and p75 on peripheral mononuclear cells (MNCs) from five patients with systemic JCA and synovial MNCs from five ANA positive patients with pauciarticular JCA was evaluated by flow cytometry. RESULTS: TNF alpha serum concentrations did not differ significantly between the patients with active JCA and the control group. No correlation was found between TNF alpha and parameters of disease activity, but both p55 and p75 showed a significant positive correlation with the physician global estimate of disease activity (p < 0.001), ESR (p < 0.001), CRP (p < 0.001), and serum concentrations of IL-6 (p < 0.001). Serum concentrations of haemoglobin correlated inversely with the concentrations of p55 and p75 (p < 0.001). Synovial lymphocytes selectively expressed the p75 surface receptor. CONCLUSIONS: sTNFRp55 and sTNFRp75 each represent a sensitive marker of disease activity in JCA. Their increased expression in biological fluids may support the hypothesis that TNF alpha has a role in the pathogenesis of JCA. 相似文献
993.
JANE P. F. BAI HAE-JIN HONG DAVID A. ROTH ENBERGER W. DOUGLAS WONG JOHN G. BULS 《The Journal of pharmacy and pharmacology》1996,48(11):1180-1184
The aim of this research is to characterize the presence of insulin-degrading enzyme in human colon and ileal mucosal cells. Biochemical studies, including the activity-pH profiles, the effects of enzyme inhibitors, immunoprecipitation and western blots, were conducted. The majority of insulin-degrading activity in colon mucosal cells was localized in the cytosol. In both colon and ileum, cytosolic insulin-degrading activities had a pH optimum at pH 7.5, and were extensively inhibited by each of N-ethylmaleimide, p-chloromercuribenzoate, and 1,10-phenanthroline, but were very weakly affected by each of leupeptin, chymostatin, diisopropyl phosphofluoridate and soybean trypsin inhibitor. In the colon and ileum, more than 93% and 96%, respectively, of cytosolic insulin-degrading activities were removed by the mouse monoclonal antibody to human RBC insulin-degrading enzyme, as compared with less than 20% by the normal mouse IgG for both tissues. Further, a western blot analysis revealed that a cytosolic protein of 110 kD, in both human colon and ileum, reacted with the monoclonal antibody to insulin-degrading enzyme. It is concluded that insulin-degrading enzyme is present in the cytosol of human colon and ileal mucosal cells. 相似文献
994.
Bradykinin-induced release of PGI2 from aortic endothelial cell lines: responses mediated selectively by Ca2+ ions or a staurosporine-sensitive kinase.
下载免费PDF全文
![点击此处可从《British journal of pharmacology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
1. Bradykinin (100 nM) triggers release of nitric oxide and prostacyclin from both AG07680A and AG04762 bovine cultured aortic endothelial cells. The exposure of these cells to bradykinin is in each case associated with a striking rise in intracellular calcium ion concentration. 2. Exposure of AG07680A cells to 250 nM ionomycin was followed also by a significant release of prostacyclin, whereas 250 nM ionomycin had no capacity to stimulate release of prostacyclin from AG04762 cells. 3. There was a similar concentration-dependent increase in intracellular calcium ion concentration on exposure of AG07680A and AG04762 cells to ionomycin. 4. Exposure of AG04762 cells for 10 min to staurosporine produced a concentration-dependent inhibition (IC50 = 107 +/- 14 nM) in bradykinin-stimulated prostacyclin release. There was no similar inhibitory effect of staurosporine in AG07680A cells. 5. Bradykinin (10 nM) triggered release of nitric oxide from both AG07680A and AG04762 cells, and the effect was not inhibited by 500 nM staurosporine. There was a similar ionomycin-dependent release of nitric oxide from both cell types. 6. These results identify a common pathway for bradykinin-dependent nitric oxide release from both AG07680A and AG04762 cells, involving increases in intracellular calcium ion concentration. In contrast, the bradykinin-dependent release of prostacyclin may involve one of two pathways (involving an increase in intracellular calcium or activation of a staurosporine-sensitive kinase), and the two pathways are selectively exploited in AG07680A and AG04762 cells, respectively. 相似文献
995.
Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. 总被引:9,自引:0,他引:9
下载免费PDF全文
![点击此处可从《The Journal of clinical investigation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
H J Schnittler F Mahner D Drenckhahn H D Klenk H Feldmann 《The Journal of clinical investigation》1993,91(4):1301-1309
Marburg and Ebola virus, members of the family Filoviridae, cause a severe hemorrhagic disease in humans and primates. The disease is characterized as a pantropic virus infection often resulting in a fulminating shock associated with hemorrhage, and death. All known histological and pathophysiological parameters of the disease are not sufficient to explain the devastating symptoms. Previous studies suggested a nonspecific destruction of the endothelium as a possible mechanism. Concerning the important regulatory functions of the endothelium (blood pressure, anti-thrombogenicity, homeostasis), we examined Marburg virus replication in primary cultures of human endothelial cells and organ cultures of human umbilical cord veins. We show here that Marburg virus replicates in endothelial cells almost as well as in monkey kidney cells commonly used for virus propagation. Our data support the concept that the destruction of endothelial cells resulting from Marburg virus replication is a possible mechanism responsible for the hemorrhagic disease and the shock syndrome typical of this infection. 相似文献
996.
To improve the appropriateness and efficiency of diagnostic serological tests and subsequent antibiotic treatment, clinical data from 102 patients with unclassified arthritis were analysed to investigate whether the presence of positive IgG antibodies to Borrelia burgdorferi could be predicted. The clinical data were blindly ranked from 1 to 4 (1, Lyme arthritis unlikely; 4, Lyme arthritis very likely). Antibodies to B burgdorferi were positive in nine of 102 patients (9%). Six of 15 (40%) patients with rank numbers 3 and 4 were positive for antibodies to B burgdorferi, in contrast with only three of 87 (3%) patients with rank numbers 1 and 2. The likelihood ratio of positive Lyme serology for patients ranked 3 and 4 was 12.0, for patients ranked 2 to 4, 4.5, and for patients with arthritis of the knee, 3.0. These likelihood ratios were associated with a post-test probability of 55, 30, and 20% respectively. The clinical history in patients with unclassified arthritis can largely predict the presence of antibodies to B burgdorferi. The absolute value of a likelihood ratio can be a contributing factor in deciding to request tests for antibodies to B burgdorferi in patients with unclassified arthritis. 相似文献
997.
J. M. Johnston P. Grondziowski R. M. Windisch R. A. Eder L. Lytle 《Acta diabetologica》1995,32(4):213-216
A feasibility study was undertaken to evaluate laboratory phlebotomists performing bedside glucose monitoring (BGM) over a
3-month period on a medical and surgical floor. Specific questions included: feasibility of providing testing on a 24-h basis,
accuracy, appropriate utilization, effect on patient care, and an analysis of cost. In all, 1975 tests were performed on 114
patients. BGM results were within 15% of the laboratory's result 97% of the time. Patient and physician satisfaction was high.
Although the cost of BGM is slightly higher than a laboratory glucose test, its use appeared to reduce the length of hospital
stay by 0.47 days. Practical information on initiating a highly successful BGM program is provided. 相似文献
998.
Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. 总被引:6,自引:1,他引:5
下载免费PDF全文
![点击此处可从《The Journal of clinical investigation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
H Chiao S Foster R Thomas J Lipton R A Star 《The Journal of clinical investigation》1996,97(9):2038-2044
Alpha-Melanocyte-stimulating hormone (MSH) is a potent anti-inflammatory agent in many models of inflammation, suggesting that it inhibits a critical step common to different forms of inflammation. We showed previously that alpha-MSH inhibits nitric oxide (NO) production in cultured macro-phages. To determine how alpha-MSH acts in vivo, we induced acute hepatic inflammation by administering endotoxin (LPS) to mice pretreated with Corynebacterium parvum, alpha-MSH prevented liver inflammation even when given 30 min after LPS administration. To determine the mechanisms of action of alpha-MSH, we tested its influence on NO, infiltrating inflammatory cells, cytokines, and chemokines. Alpha-MSH inhibited systemic NO production, hepatic neutrophil infiltration, and increased hepatic mRNA abundance for TNF alpha, and the neutrophil and monocyte chemokines (KC/IL-8 and MCP-1). We conclude that alpha-MSH prevents LPS-induced hepatic inflammation by inhibiting production of chemoattractant chemokines which then modulate infiltration of inflammatory cells. Thus, alpha-MSH has an effect very early in the inflammatory cascade. 相似文献
999.
1000.